Terms: = Prostate cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Diagnosis
4 results:
1. Social inequalities and cancer: can the European deprivation index predict patients' difficulties in health care access? a pilot study.
Moriceau G; Bourmaud A; Tinquaut F; Oriol M; Jacquin JP; Fournel P; Magné N; Chauvin F
Oncotarget; 2016 Jan; 7(1):1055-65. PubMed ID: 26540571
[TBL] [Abstract] [Full Text] [Related]
2. Single nucleotide polymorphisms in DNA repair genes as risk factors associated to prostate cancer progression.
Henríquez-Hernández LA; Valenciano A; Foro-Arnalot P; Álvarez-Cubero MJ; Cozar JM; Suárez-Novo JF; Castells-Esteve M; Fernández-Gonzalo P; De-Paula-Carranza B; Ferrer M; Guedea F; Sancho-Pardo G; Craven-Bartle J; Ortiz-Gordillo MJ; Cabrera-Roldán P; Herrera-Ramos E; Rodríguez-Gallego C; Rodríguez-Melcón JI; Lara PC
BMC Med Genet; 2014 Dec; 15():143. PubMed ID: 25540025
[TBL] [Abstract] [Full Text] [Related]
3. [Conformal radiotherapy for prostate cancer].
Tkachev SI; Matveev VB; Trofimova OP; Nazarenko AV; Pylova IV; Priamikova IuI
Vopr Onkol; 2010; 56(2):215-9. PubMed ID: 20552901
[TBL] [Abstract] [Full Text] [Related]
4. DNA repair gene XRCC1 and xpd polymorphisms and risk of prostate cancer.
Rybicki BA; Conti DV; Moreira A; Cicek M; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):23-9. PubMed ID: 14744728
[TBL] [Abstract] [Full Text] [Related]